Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Zolpidem tartrate
Medication labelZolpidem tartrate tablets, USP are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.…
Why this: Advisory · dailymed-prescription
Zolpidem tartrate tablets, USP are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets, USP have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [ see Clinical Studies (14)] . The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.
- generic_name
- zolpidem tartrate
- product_names
- zolpidem tartrate
- ndc
- 60760-515, 13668-007, 60760-515-30, 60760-515-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en